Register Now
Course Information

About the Symposium

This symposium is designed to improve competence to assess and treat patients with brain tumors or brain and spine tumor metastases, especially as it relates to comparing treatments for brain and spine metastases, evaluating new technologies, treating sellar and parasellar brain tumors, and assessing and treating gliomas, with the overall goal of improving outcomes in these patient populations. The Brain Tumor Partners in Care Session is designed to guide the attendees clinical practice through understanding the metastatic brain tumor patient experience. Experts will present on topics relating to the management of patients with brain metastases including pathophysiology, clinical management, psychosocial implications & planning for end-of-life with a focus session on lung cancer & brain metastasis.

Target Audience

Neurosurgeons, Radiation Oncologists, Medical Oncologists, Neuro-oncologists, Neurologists, Physician Assistants, Nurse Practitioners, Nurses and allied healthcare professionals who work with patients with tumors.

Objectives

At the completion of this activity, the participant will be able to:

  • Compare and contrast the available options for treating spinal tumor metastases, including radiosurgery, radiofrequency ablation, laser interstitial thermal therapy, and minimally invasive surgery.
  • Debate the issues comparing surgery vs radiosurgery and preoperative radiosurgery vs postoperative radiation therapy for single or multiple brain metastases.
  • Describe the evidence supporting use of new therapeutic approaches for brain metastases including immunotherapy and targeted therapy.
  • Critically appraise technological innovations in imaging and surgery for brain tumor management.
  • List the various types of sellar and parasellar brain tumors and describe criteria for selecting the best radiosurgery and surgery options.
  • Describe advances in genomics, imaging, neuropathology, and medical management of gliomas.
  • Review the pathophysiology, assessment, clinical implications, standard of care and advances in treatments of patients with metastatic brain tumors.
  • Identify the holistic needs of the brain metastasis patient from pre-diagnosis to end-of-life.

Call For Papers

Abstracts will be solicited for electronic poster presentations. Electronic posters will be on display during breaks and lunch. Poster participants will be notified of acceptance as well as poster format and content requirements on or before October 4, 2019.

Abstract Requirements

  • Deadline date: September 27, 2019. One entry per presenter.
  • Submit your abstract as a Word document to Brigid Walters at walterb4@ccf.org
  • 300 word limit